INAB · In8bio, Inc.
$1.11
-0.08 (-6.72%)
At close · Jul 28
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company’s business strategy, its existing cash of $21.9 million as of March 31, 2026 is not anticipated to fund the Company’s projected operating expenses and capital expenditure requirements for a period of at least 12 months from the date of issuance of these condensed financial statements, and accordingly, there is substantial doubt about the Company’s ability to continue to operate as a going concern.”View the 10-Q filed May 7, 2026
Market Cap
$10.93M
Shares
9.85M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.